13FPulse
AX

AXSM AXSOME THERAPEUTICS INC

2026Q2 · CUSIP 05464T104 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
494
Institutions that reported holding it to the SEC
Net increase in holders
+88
Last quarter 406 → now 494
How unusual is that
Top 5%
Stronger buying than 98% of US stocks
What the filings say, in one paragraph

494 funds held AXSM at the end of 2026Q2, up 88 from the quarter before. That is stronger buying than 97.7% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $777M(YoY +56.9%), return on equity is -230.1%. AXSM has had 12 buying rushes in its history, and the price moved +44.6% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2016Q1: holders=17 2016Q2: holders=35 2016Q3: holders=35 2016Q4: holders=40 2017Q1: holders=48 2017Q2: holders=34 2017Q3: holders=29 2017Q4: holders=34 2018Q1: holders=35 2018Q2: holders=33 2018Q3: holders=34 2018Q4: holders=35 2019Q1: holders=63 2019Q2: holders=106 2019Q3: holders=111 2019Q4: holders=167 2020Q1: holders=159 2020Q2: holders=189 2020Q3: holders=171 2020Q4: holders=177 2021Q1: holders=181 2021Q2: holders=174 2021Q3: holders=169 2021Q4: holders=166 2022Q1: holders=175 2022Q2: holders=172 2022Q3: holders=187 2022Q4: holders=219 2023Q1: holders=194 2023Q2: holders=227 2023Q3: holders=221 2023Q4: holders=241 2024Q1: holders=255 2024Q2: holders=256 2024Q3: holders=278 2024Q4: holders=292 2025Q1: holders=347 2025Q2: holders=346 2025Q3: holders=353 2025Q4: holders=396 2026Q1: holders=406 2026Q2: holders=494 -88 -44 +0 +44 +88 15267519 16Q117Q218Q319Q421Q122Q223Q324Q426Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 12 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 5%
2025Q4 Top 20% +23.9%
2025Q1 Top 5% +2.8% +34.4%
2024Q3 Top 20% +49.0% +12.9%
2023Q2 Top 10% -11.1% +32.5%
2022Q4 Top 20% +20.1% +10.5%
2022Q3 Top 10% +29.5% +47.2%
2020Q2 Top 20% -9.1% -11.7%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
218
Change in large funds
+34
Total value they hold
$9.6B
Funds buying for the first time
137
Funds that sold out entirely
49
Price change that quarter
-7.7%
Funds holding puts (bearish)
13
Funds holding calls (bullish)
18

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-3.74
EPS YoY
Revenue (TTM)
$0.8B
Revenue YoY
+56.9%
Net margin
-24.7%
ROE
-230.1%
Debt ratio
89.1%
FCF (TTM)
-$72M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.93 2021-12-31: EPS -0.90 2022-03-31: EPS -1.06 2022-06-30: EPS -1.06 2022-09-30: EPS -1.07 2022-12-31: EPS -1.41 2023-03-31: EPS -0.26 2023-06-30: EPS -1.54 2023-09-30: EPS -1.32 2023-12-31: EPS -2.15 2024-03-31: EPS -1.44 2024-06-30: EPS -1.67 2024-09-30: EPS -1.34 2024-12-31: EPS -1.54 2025-03-31: EPS -1.22 2025-06-30: EPS -0.97 2025-09-30: EPS -0.94 2025-12-31: EPS -0.55 2026-03-31: EPS -1.26 2026-06-30: EPS -0.99 0M 109M 218M $M -2.37 -1.18 0.00 20212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-55M-27M988K 20162017201820192020202120222023202420252026
Latest quarter $-21M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.